Company Filing History:
Years Active: 1998
Title: Kurt Gce Van Daele: Innovator in Gastrointestinal Pharmacology
Introduction
Kurt Gce Van Daele is a notable inventor based in Antwerp-Borgerhout, Belgium. He has made significant contributions to the field of pharmacology, particularly in the area of gastrointestinal motility. His work has implications for the treatment of conditions affecting the gastrointestinal system.
Latest Patents
Kurt Gce Van Daele holds a patent for N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran, and N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives. This patent also covers their N-oxide forms and pharmaceutically acceptable salts that possess gastrointestinal motility stimulating properties. The compositions containing these compounds serve as active ingredients and provide methods for treating warm-blooded animals suffering from decreased peristalsis of the gastrointestinal system. He has 1 patent to his name.
Career Highlights
Kurt Gce Van Daele is associated with Janssen Pharmaceutica N.V., a leading company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative solutions for gastrointestinal issues, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Kurt has collaborated with notable colleagues, including Georges H Van Daele, who is now deceased, and Frans M Van Den Keybus. These collaborations have enriched his research and development efforts in the pharmaceutical field.
Conclusion
Kurt Gce Van Daele is a distinguished inventor whose work in gastrointestinal pharmacology has the potential to improve treatment options for various conditions. His contributions through patents and collaborations highlight his commitment to advancing medical science.